## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "ASCCP Management Guidelines"
developer_entity: "American Society for Colposcopy and Cervical Pathology Inc"
bundle_id: "org.asccp.app2019"
app_store_id: "1498550832"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Paid"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-03-04"
report_date: "2026-04-18"
report_version: "2.4.1"
total_reviews: 8522
overall_rating: 4.76
sentiment: "Mixed"
sentiment_score: 42
confidence: "high"
confidence_score: 0.95
data_age_days: 0
intelligence_version: 3
tags: ["medical", "paid", "mixed sentiment", "mobile app", "app review", "app analysis", "healthcare", "professionals,", "clinicians,"]
canonical_url: "https://marlvel.ai/intel-report/medical/asccp-management-guidelines"
license: "CC-BY-NC 4.0"
---

# ASCCP Management Guidelines App Audit

> **TL;DR:** ASCCP Management Guidelines is a medical app by American Society for Colposcopy and Cervical Pathology Inc, rated 4.76/5 by 8.5K users, with Mixed user sentiment (42/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** ASCCP Management Guidelines shows Mixed sentiment (4.76/5 from 8.5K reviews) — users praise clinical utility but report issues with ui/ux regression.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 4.76/5 (8.5K reviews) |
| **User Mood** | Mixed |
| **Category** | Medical |
| **Developer** | American Society for Colposcopy and Cervical Pathology Inc |
| **Pricing** | Paid |
| **Platforms** | iOS & Android |
| **Confidence** | High (0.95/1.0) |
| **Data Age** | 0d |

## Metadata & Market Performance
- **Publisher:** American Society for Colposcopy and Cervical Pathology Inc
- **Category:** Medical
- **Target Audience:** Healthcare professionals, clinicians, and medical practitioners involved in the diagnosis and management of cervical cancer and HPV-related diseases.
- **Platforms:** iOS & Android
- **Version Audited:** 2.4.1
- **Audit Date:** 2026-04-18
- **Signal Count:** 8522 reviews analyzed
- **Confidence:** High (0.95/1.0)
- **App Store ID (iOS):** 1498550832
- **Bundle ID:** org.asccp.app2019
- **Google Play ID:** org.asccp.app2019
- **Performance Trend:** Declining
- **Data Window:** Analysis based on signals collected up to 2026-04-18
- **Short Description:** ASCCP Management Guidelines- There’s an app for that!

<!-- section:executive-snapshot -->
## Executive Snapshot
*This report is informational only and not medical advice.* ASCCP Management Guidelines is a specialized clinical decision support tool for healthcare professionals managing abnormal cervical cancer screening results. It holds a strong market position as the #5 Paid app in the Medical category (US), differentiating itself through interactive risk-based management algorithms and tap-to-calculate functionality that streamlines complex consensus guidelines for busy clinicians.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] Risk-Based Management Algorithms:** Interactive decision support tools for managing abnormal cervical cancer screening results.
- **[Differentiator] Clinical Decision Calculator:** Tap-to-calculate functionality to determine next-step recommendations in seconds.
- **[Differentiator] Real-time Guideline Updates:** Push alerts and content updates for current evidence-based recommendations.
  * *User Intent:* Users want timely prompts to stay engaged without missing updates.
<!-- /section:features -->

## Monetization Strategy
- **Model:** Paid
- **Tiers:** One-time purchase of $14.99
- **Price:** iOS: $14.99 | Android: $14.99
- **Analysis:** The app uses a direct paid model targeting professionals, with additional value provided to society members via free access and upcoming CME credit integration.

<!-- section:sentiment -->
## 🟡 User Sentiment (High Confidence: 8.5K reviews)
- **Overall Rating:** 4.76/5
- **Platform Split:** iOS 4.8/5 (8.2K ratings) | Android 4.5/5 (300 ratings)
- **Overall Sentiment:** Mixed

### Top Praises
- **Clinical Utility**

### Top Complaints (Impact Areas)
- **UI/UX Regression**
- **Technical Bugs & Crashes**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis

**Core Strengths:**
- High clinical authority and consensus-based content
- Strong category ranking (#5 Paid Medical)
- Interactive decision-support tools (calculators)

**Critical Frictions:**
- Recent UI/UX regression causing user confusion
- Android-specific navigation bugs (button overlap)
- Clinical recommendation discrepancies between app and web

**Growth Levers:**
- Integration of CME credits for professional development
- Expansion of HPV self-collection guidelines

**Market Threats:**
- Declining sentiment trend impacting long-term adoption
- Clinical liability risks from app/web data mismatches

<!-- /section:swot -->
## What's Changed (v2 → v3)
The app is experiencing a critical UX and technical regression that is undermining its authoritative clinical position, despite the addition of new content.

- **[HIGH]** **[Declined] Sentiment and UX Regression:** User sentiment has shifted to 'mixed' due to severe navigation issues and UI confusion following recent updates.
- **[HIGH]** **[Added] Clinical Data Discrepancy:** New weakness identified regarding inconsistencies between app-based recommendations and official web guidelines, posing a clinical safety risk.
- [MED] **[Shifted] Feature Set Consolidation:** The feature list has been condensed, emphasizing the 'Clinical Decision Calculator' as the core differentiator.
- [MED] **[Shifted] Maintenance Mode Status:** The app's development lifecycle is now categorized as 'maintenance mode' with infrequent updates and a lack of iterative performance improvements.

<!-- section:whats-new -->
## What's New

- **Latest (v2.4, 5 months ago):** Added support for HPV self-collection recommendations.
<!-- /section:whats-new -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway)

ASCCP Management Guidelines is an established medical app that is a paid app.
With a 4.76/5 rating from 8.5K reviews, it shows polarized user reception.

<!-- speakable-start -->
> **Bottom Line:** ASCCP Management Guidelines is an essential clinical tool currently facing a critical UX crisis. While its authoritative content and #5 category ranking provide a strong foundation, the recent UI regression and clinical data discrepancies between mobile and web platforms represent significant retention and safety risks that must be addressed immediately.
<!-- speakable-end -->

**Best for:** Healthcare professionals, clinicians, and medical practitioners involved in the diagnosis and management of cervical cancer and HPV-related diseases.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [HIGH] Fix Android navigation bar overlap — *Users report the 'next' button is inaccessible on some devices, preventing completion of clinical pathways (top technical complaint).*
- [ ] [HIGH] Audit and synchronize clinical data with web version — *Medium-frequency complaints indicate the app provides different recommendations than the web version, posing a clinical safety risk.*
- [ ] [MEDIUM] Simplify the 'Timeline' UI — *High-frequency feedback describes the new update as 'horribly confusing' and 'difficult to navigate' compared to previous versions.*
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Declining

- 🔴 Recent UI/UX overhaul described as 'horribly confusing' by long-term users — Mixed mood.
- 🔴 Reports of clinical recommendation discrepancies between app and web platforms — safety risk.
- 🟢 v2.4 added HPV self-collection recommendations — active alignment with evolving screening standards.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 4.76/5 |
| Total Reviews | 8.5K |
| Sentiment | Mixed (42/100) |
| Confidence | High |
| Pricing Model | Paid |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Trend | Declining |
| Outlook | Declining |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **ASCCP Management Guidelines** (this app) | 4.76/5 | Mixed | American Society for Colposcopy and Cervical Pathology Inc |
| [Beat Social Phobia with AJ](https://marlvel.ai/intel-report/medical/beat-social-phobia-with-aj) | 3.9/5 | Thrilled | Universal Relaxation Ltd |
| [Move On with AJ](https://marlvel.ai/intel-report/medical/move-on-with-aj) | 4.3/5 | Excited | Universal Relaxation Ltd |
| [Clarity Mobile App](https://marlvel.ai/intel-report/medical/clarity-mobile-app) | 3.5/5 | N/A | Clarity Benefit Solutions |
| [King of Budz Dispensary](https://marlvel.ai/intel-report/medical/com-kingofbudz) | 4.9/5 | N/A | Pufformance Technologies |
| [DAS Calculator](https://marlvel.ai/intel-report/medical/das-calculator) | 4.8/5 | N/A | Greg Fiumara |

## Company Profile
- **Developer:** American Society for Colposcopy and Cervical Pathology Inc
- **Website:** [https://www.asccp.org/](https://www.asccp.org/)
- **Social:** [Instagram](https://www.instagram.com/asccp1) · [Facebook](https://www.facebook.com/ASCCP) · [X/Twitter](https://twitter.com/ASCCP) · [LinkedIn](https://www.linkedin.com/company/asccp)

## Data Sources & Links
- **App Store:** [View on Apple Store](https://apps.apple.com/us/app/asccp-management-guidelines/id1498550832?uo=4)
- **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=org.asccp.app2019&hl=en&gl=us)
- **Dev Site:** [Official Website](https://www.asccp.org/)
- **Sources:** Developer website content, About us / company information, App store metadata, User reviews.

## Related Intel Reports
- [*Beat Social Phobia with AJ*](https://marlvel.ai/intel-report/medical/beat-social-phobia-with-aj) (Universal Relaxation Ltd) — 3.9/5 Rating | Excellent Sentiment
- [*Move On with AJ*](https://marlvel.ai/intel-report/medical/move-on-with-aj) (Universal Relaxation Ltd) — 4.3/5 Rating | Positive Sentiment
- [*Clarity Mobile App*](https://marlvel.ai/intel-report/medical/clarity-mobile-app) (Clarity Benefit Solutions) — 3.5/5 Rating | N/A Sentiment
- [*King of Budz Dispensary*](https://marlvel.ai/intel-report/medical/com-kingofbudz) (Pufformance Technologies) — 4.9/5 Rating | N/A Sentiment
- [*DAS Calculator*](https://marlvel.ai/intel-report/medical/das-calculator) (Greg Fiumara) — 4.8/5 Rating | N/A Sentiment
- [*LTC SOM Regs*](https://marlvel.ai/intel-report/medical/com-markail-ftag-inspector) (MarKail & Associates Limited) — 4.5/5 Rating | Positive Sentiment
- [*HESI A2 Test Prep Mastery 2026*](https://marlvel.ai/intel-report/medical/hesi-a2-test-prep-mastery-2026) (Higher Learning Technologies) — 4.6/5 Rating | N/A Sentiment
- [*PlushCare: Online Doctor*](https://marlvel.ai/intel-report/medical/plushcare-online-doctor) (Accolade, Inc.) — 4.8/5 Rating | N/A Sentiment
- [*Misophonia Reflex Finder*](https://marlvel.ai/intel-report/medical/misophonia-reflex-finder) (Thomas Dozier) — 4.3/5 Rating | N/A Sentiment
- [*Recognise Neck*](https://marlvel.ai/intel-report/medical/com-noigroup-recognise-neckv2) (noigroup) — 3.7/5 Rating | N/A Sentiment

## Methodology

This report was generated by Marlvel.ai's 3-stage AI intelligence pipeline:

1. **Feature & Positioning Extraction** — Analyzes app metadata, developer website content, and version history to identify key features, target audience, and competitive positioning.
2. **Sentiment Analysis** — Processes user reviews (minimum 5 reviews required) to extract praise themes, complaint themes, and overall sentiment with evidence quotes.
3. **Intelligence Synthesis** — Combines stages 1 & 2 with App Store rankings to produce SWOT analysis, executive summary, and actionable insights.

- **Confidence Score:** 0.95/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 8.5K
- **Data Sources:** user reviews, developer website, company about page, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 0 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/asccp-management-guidelines)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.